Dr. Mark Groves, MD

  • Greenwich, CT
  • Neurologist
NPI1891786380
Part D claims, 2024
2,242
Publications
10
Hospital affiliations
1
Industry payments
$15
Medical groups
2
Practice address
5 Perryridge Rd, Greenwich, CT 06830
Practice phone
Call (203) 863-3000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Greenwich Hospital

Hospital · Greenwich, Connecticut

See all 4 affiliations

Find Dr. Groves' professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mark Groves is a neurologist in Greenwich, Connecticut

Dr. Groves practices at Greenwich Hospital in Greenwich, Connecticut, part of Yale New Haven Health System.

Dr. Groves' NPI, 1891786380, was assigned on November 2, 2005. Dr. Groves holds New York license 214706.

NPI and contact details
NPI enumeration date
November 2, 2005
NPI status
Active
Practice phone
(203) 863-3000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data

Dr. Mark Groves practices at Greenwich Hospital in Greenwich, Connecticut

Dr. Groves' primary practice is Greenwich Hospital, at 5 Perryridge Rd, Greenwich, CT 06830 in Fairfield County. The practice phone is (203) 863-3000.

  • Greenwich Hospital
    5 Perryridge Rd, Greenwich, CT 06830 · Fairfield CountyPhone(203) 863-3000

Source: Dmand AI Affiliation Data

Dr. Mark Groves is affiliated with 2 sites of care and 2 medical groups

Dr. Groves' primary practice is Greenwich Hospital in Greenwich, Connecticut, part of Yale New Haven Health System. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Groves to 1 more group practice or clinic and 1 medical group, each named with a free account.

See all 4 affiliations for Dr. Groves

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Mark Groves' practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Groves practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Greenwich HospitalAvailable with a free account
+1 more site and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Groves practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Yale New Haven Health System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mark Groves is one of 302 neurologists in Connecticut

Neurology is Dr. Groves' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Groves is licensed in New York.

Specialties and state licenses

  • Neurology, New YorkPrimaryLicense 214706 · taxonomy 2084N0400X

Neurologists near Dr. Groves

Counts of neurologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mark Groves' patients have a median age of 79

Across all payers, Dmand AI patient panel data puts Dr. Groves' median patient age at 79, with 60% women.

Dr. Groves' patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 79

Patient panel by sex, all payers

  • Women60%
  • Men40%

Source: Dmand AI Patient Panel Data

Dr. Mark Groves wrote 2,242 Medicare Part D claims in 2024

In 2024, Dr. Groves wrote 2,242 Medicare Part D claims for 161 patients. 89% of them were for generic drugs. CMS names the drug for 1,994 of them, across 36 drugs with 11 or more claims each, at $489,288 in total drug cost. In 2023, CMS named 2,011 claims across 33 drugs.

Part D claims, 20242,242
Drugs named by CMS36
Total drug cost$489,288
Part D patients161

Dr. Groves' Part D claims by kind of drug, 2024

  • Generic2,001 claims89%
  • Brand-name241 claims11%

Dr. Groves' most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Groves' Part D claims, 2024

  • Antipsychotics, patients 65 and over18%404 of 2,242 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2,0112024: 1,9941%

Drugs named by CMS: 36 in 2024, 33 in 2023.

See all prescribing by Dr. Groves

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

For MedTech and pharma teams

Find neurologists like Dr. Groves by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mark Groves has 10 publications on record

Dmand AI links 10 papers to Dr. Groves, published from 2010 to 2018. 2011 was the busiest year, with 3. The most frequent topics are Parkinson Disease, Huntington Disease and Leucine-Rich Repeat Serine-Threonine Protein Kinase-2. Dr. Groves has published most often in PLoS Curr. Dr. Groves' most frequent co-authors are Susan B. Bressman, MD, Karen S. Marder, MD and Vicki L. Shanker, MD.

Papers10
Years published2010 to 2018

Dr. Groves' papers by year, 2010 to 2018

Topics Dr. Groves writes about most

  • Parkinson Disease
  • Huntington Disease
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Psychiatric Status Rating Scales

Dr. Groves' most frequent co-authors

Recent publications by Dr. Groves

See all 10 publications and co-authors

See who Dr. Groves researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Groves works with, so you can find a warm path to the right neurologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Mark Groves received $15 in industry payments in 2017

CMS Open Payments shows 1 general payment to Dr. Groves from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. ACADIA Pharmaceuticals Inc paid the most, $15.

Companies that paid Dr. Groves the most, 2017 to 2017

Share is of all general payments to this clinician.

See all payments to Dr. Groves

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Mark Groves's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mark Groves

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mark Groves' NPI number?

Dr. Mark Groves' NPI number is 1891786380. It was assigned on November 2, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Mark Groves?

Dr. Mark Groves is a neurologist in Greenwich, Connecticut. The primary specialty in the NPI Registry is Neurology Physician (taxonomy code 2084N0400X).

Where does Dr. Mark Groves practice?

Dr. Groves practices at 5 Perryridge Rd, Greenwich, CT 06830. Dr. Groves' primary practice is Greenwich Hospital in Greenwich, Connecticut, part of Yale New Haven Health System. Dmand AI also links Dr. Groves to 1 group practice or clinic and 1 medical group.

What is Dr. Mark Groves' office phone number?

The practice phone on file for Dr. Groves is (203) 863-3000.

What is Dr. Mark Groves' medical license number?

Dr. Groves holds New York license 214706.

Which hospitals is Dr. Mark Groves affiliated with?

Dr. Groves practices at Greenwich Hospital in Greenwich, Connecticut.

What medical group is Dr. Mark Groves part of?

Dr. Groves is linked to Mount Sinai Institute for Liver Medicine. Dmand AI links Dr. Groves to 1 more medical group.

What drugs does Dr. Mark Groves prescribe most?

In 2024 Medicare Part D data, Dr. Groves' most prescribed drugs by claims were Clozapine, Clonazepam and Mirtazapine.

Has Dr. Mark Groves received payments from drug or device companies?

CMS Open Payments shows $15 in general payments to Dr. Groves from 1 company from 2017 to 2017. The largest total came from ACADIA Pharmaceuticals Inc.

How long has Dr. Mark Groves been practicing?

Dr. Groves' NPI was assigned in 2005.

Does Dr. Mark Groves do research?

Dmand AI links 10 publications to Dr. Groves, published from 2010 to 2018.

Who does Dr. Mark Groves publish with?

Dr. Groves' most frequent co-authors are Susan B. Bressman, MD (3 shared papers), Karen S. Marder, MD (3 shared papers) and Vicki L. Shanker, MD (3 shared papers).

Selling to neurology practices?

See neurologists in Connecticut by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)